A quantitative structure-activity relationship study on a novel class of calcium-entry blockers: 1-[{4-(aminoalkoxy)phenyl}sulphony1]indolizines

被引:115
作者
Gupta, SP [1 ]
Mathur, AN
Nagappa, AN
Kumar, D
Kumaran, S
机构
[1] Birla Inst Technol & Sci, Dept Chem, Pilani 333031, Rajasthan, India
[2] Birla Inst Technol & Sci, Dept Pharm, Pilani 333031, Rajasthan, India
关键词
quantitative structure-activity relationship; calcium channel blockers; indolizines;
D O I
10.1016/j.ejmech.2003.08.001
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A quantitative structure-activity relationship (QSAR) study has been made on two different series of 1-[{4-(aminoalkoxy)phenyl}sulphonyl]indolizines acting as calcium entry blockers, using some physicochemical and structural parameters. Two different assays were reported for both the series: (IC50)A, referring to the molar concentration of the compound required to reduce [H-3] nitrendipine binding by 50%, and (IC50)(B), referring to that required to block Ca2+ induced concentration of K+ depolarised rat aorta by 50%. For series 1, where the 2-position substituents of indolizine ring were varied along with the aminoalkoxy moieties of the phenyl ring, the QSAR analysis shows that the 2-position substituents can equally affect both the activities through their hydrophobic and electronic properties and the aminoalkoxy moiety through some steric effects. For series 2, where the indolizine ring has been replaced by varying heterocyclic rings, along with the changes in aminoalkoxy moiety of the phenyl ring, the QSAR exhibits that these different heterocyclic rings affect both the activities through some steric roles, altering the conformations of the receptors from system A to system B. Among the different heterocyclic rings, the N-substituted indole ring is shown to be more conducive to both the activities than any other ring. However, a 5-membered ring is indicated to be less effective than a 9- or 10-membered ring for activity B. Additionally, the amino moieties having phenyl ring with methoxy groups at 3,4,and 5-positions are shown to favour both A and B activities. (C) 2003 Editions scientifiques et medicales Elsevier SAS. All rights reserved.
引用
收藏
页码:867 / 873
页数:7
相关论文
共 20 条
  • [1] DIHYDROPYRIMIDINE CALCIUM-CHANNEL BLOCKERS .2. 3-SUBSTITUTED-4-ARYL-1,4-DIHYDRO-6-METHYL-5-PYRIMIDINECARBOXYLIC ACID-ESTERS AS POTENT MIMICS OF DIHYDROPYRIDINES
    ATWAL, KS
    ROVNYAK, GC
    KIMBALL, SD
    FLOYD, DM
    MORELAND, S
    SWANSON, BN
    GOUGOUTAS, JZ
    SCHWARTZ, J
    SMILLIE, KM
    MALLEY, MF
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (09) : 2629 - 2635
  • [2] BOLGER GT, 1983, J PHARMACOL EXP THER, V225, P291
  • [3] 4-ARYLDIHYDROPYRIDINES, A NEW CLASS OF HIGHLY-ACTIVE CALCIUM-ANTAGONISTS
    BOSSERT, F
    MEYER, H
    WEHINGER, E
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION IN ENGLISH, 1981, 20 (09): : 762 - 769
  • [4] Diltiazem-like calcium entry blockers: A hypothesis of the receptor-binding site based on a comparative molecular field analysis model
    Corelli, F
    Manetti, F
    Tafi, A
    Campiani, G
    Nacci, V
    Botta, M
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (01) : 125 - 131
  • [5] (-)-H-3 DESMETHOXYVERAPAMIL LABELING OF PUTATIVE CALCIUM CHANNELS IN BRAIN - AUTORADIOGRAPHIC DISTRIBUTION AND ALLOSTERIC COUPLING TO 1,4-DIHYDROPYRIDINE AND DILTIAZEM BINDING-SITES
    FERRY, DR
    GOLL, A
    GADOW, C
    GLOSSMANN, H
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1984, 327 (02) : 183 - 187
  • [6] CRYSTAL-STRUCTURES AND PHARMACOLOGICAL ACTIVITY OF CALCIUM-CHANNEL ANTAGONISTS - 2,6-DIMETHYL-3,5-DICARBOMETHOXY-4-(UNSUBSTITUTED, 3-METHYL-PHENYL, 4-METHYL-PHENYL, 3-NITRO-PHENYL, 4-NITRO-PHENYL, AND 2,4-DINITROPHENYL)-1,4-DIHYDROPYRIDINE
    FOSSHEIM, R
    SVARTENG, K
    MOSTAD, A
    ROMMING, C
    SHEFTER, E
    TRIGGLE, DJ
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1982, 25 (02) : 126 - 131
  • [7] NOVEL HETEROCYCLIC-ANALOGS OF THE NEW POTENT CLASS OF CALCIUM ENTRY BLOCKERS - 1-[[4-(AMINOALKOXY)PHENYL]SULFONYL]INDOLIZINES
    GUBIN, J
    DEVOGELAER, H
    INION, H
    HOUBEN, C
    LUCCHETTI, J
    MAHAUX, J
    ROSSEELS, G
    PEIREN, M
    CLINET, M
    POLSTER, P
    CHATELAIN, P
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (10) : 1425 - 1433
  • [8] A NOVEL CLASS OF CALCIUM-ENTRY BLOCKERS - THE 1-[[4-(AMINOALKOXY)PHENYL]SULFONYL]INDOLIZINES
    GUBIN, J
    LUCCHETTI, J
    MAHAUX, J
    NISATO, D
    ROSSEELS, G
    CLINET, M
    POLSTER, P
    CHATELAIN, P
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (06) : 981 - 988
  • [9] Gupta SP, 2001, PROG DRUG RES, V56, P121
  • [10] Hansch C., 1979, Substituent constants for correlation analysis in chemistry and biology